Home > Journals > Medicine > Bulletin du cancer > summary
 
      Advanced search    Shopping cart    French version 
 
Latest books
Catalogue/Search
Collections
All journals
Medicine
Bulletin du Cancer
- Current issue
- Archives
- Subscribe
- Order an issue
- More information
Biology and research
Public health
Agronomy and biotech.
My account
Forgotten password?
Online account   activation
Subscribe
Licences IP
- Instructions for use
- Estimate request form
- Licence agreement
Order an issue
Pay-per-view articles
Newsletters
How can I publish?
Journals
Books
Help for advertisers
Foreign rights
Book sales agents



 

Texte intégral de l'article
 
Printable version

Hormone therapy for prostate cancer


Bulletin du Cancer. Volume 91, Number 1, 69-74, Janvier 2004, Synthèse

Résumé   Article gratuit  

Author(s) : Christine Théodore

Summary : Hormonal deprivation has been used for more than 60 years in the treatment of advanced prostate cancer. However, the optimal form of this therapy is still an enigma. This review discusses some of the current challenges in the hormonal management of prostate cancer, regarding complete androgen blockade, intermittent treatment and the question of whether early hormonal deprivation is superior to delayed therapy. The choice of hormone therapy for cancer of the prostate depends not only on the desired progression free survival and overall survival but also an the patient‘s quality of life and on the treatment toxicities and costs. ▴

Keywords : prostate cancer, hormonal therapy

 

About us - Contact us - Conditions of use - Secure payment
Latest news - Conferences
Copyright © 2007 John Libbey Eurotext - All rights reserved
[ Legal information - Powered by Dolomède ]